Bio-Genesys Signs Deal to Use Affy Technology in Ag Genotyping Services | GenomeWeb

NEW YORK (GenomeWeb) – British ag-bio firm Bio-Genesys Diagnostics has signed a deal to use Affymetrix technology exclusively as the foundation for its commercial agricultural genotyping services, the companies announced today.

Bio-Genesys will run all of its genetic testing services for cattle, pigs, goats, sheep, and camelids on Affymetrix's Axiom 384HT genotyping platform. According to the companies, they have already codeveloped a commercial cattle breeding array that is now available in Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.